BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10479410)

  • 1. Nuclear targeting of mutant Huntingtin increases toxicity.
    Peters MF; Nucifora FC; Kushi J; Seaman HC; Cooper JK; Herring WJ; Dawson VL; Dawson TM; Ross CA
    Mol Cell Neurosci; 1999 Aug; 14(2):121-8. PubMed ID: 10479410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.
    Cooper JK; Schilling G; Peters MF; Herring WJ; Sharp AH; Kaminsky Z; Masone J; Khan FA; Delanoy M; Borchelt DR; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 1998 May; 7(5):783-90. PubMed ID: 9536081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin.
    Hackam AS; Hodgson JG; Singaraja R; Zhang T; Gan L; Gutekunst CA; Hersch SM; Hayden MR
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1047-55. PubMed ID: 10434304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity.
    Nucifora FC; Ellerby LM; Wellington CL; Wood JD; Herring WJ; Sawa A; Hayden MR; Dawson VL; Dawson TM; Ross CA
    J Biol Chem; 2003 Apr; 278(15):13047-55. PubMed ID: 12464607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntingtin contains a highly conserved nuclear export signal.
    Xia J; Lee DH; Taylor J; Vandelft M; Truant R
    Hum Mol Genet; 2003 Jun; 12(12):1393-403. PubMed ID: 12783847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.
    Hackam AS; Singaraja R; Zhang T; Gan L; Hayden MR
    Hum Mol Genet; 1999 Jan; 8(1):25-33. PubMed ID: 9887328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyglutamine pathogenesis.
    Ross CA; Wood JD; Schilling G; Peters MF; Nucifora FC; Cooper JK; Sharp AH; Margolis RL; Borchelt DR
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1005-11. PubMed ID: 10434299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.
    Chun W; Lesort M; Tucholski J; Faber PW; MacDonald ME; Ross CA; Johnson GV
    Neurobiol Dis; 2001 Jun; 8(3):391-404. PubMed ID: 11442349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cellular model that recapitulates major pathogenic steps of Huntington's disease.
    Lunkes A; Mandel JL
    Hum Mol Genet; 1998 Sep; 7(9):1355-61. PubMed ID: 9700187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.
    Zainelli GM; Ross CA; Troncoso JC; Fitzgerald JK; Muma NA
    J Neurosci; 2004 Feb; 24(8):1954-61. PubMed ID: 14985437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats.
    Li SH; Li XJ
    Hum Mol Genet; 1998 May; 7(5):777-82. PubMed ID: 9536080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamine.
    Hazeki N; Tsukamoto T; Yazawa I; Koyama M; Hattori S; Someki I; Iwatsubo T; Nakamura K; Goto J; Kanazawa I
    Biochem Biophys Res Commun; 2002 Jun; 294(2):429-40. PubMed ID: 12051730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.
    Martindale D; Hackam A; Wieczorek A; Ellerby L; Wellington C; McCutcheon K; Singaraja R; Kazemi-Esfarjani P; Devon R; Kim SU; Bredesen DE; Tufaro F; Hayden MR
    Nat Genet; 1998 Feb; 18(2):150-4. PubMed ID: 9462744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of huntingtin protein size on nuclear localization and cellular toxicity.
    Hackam AS; Singaraja R; Wellington CL; Metzler M; McCutcheon K; Zhang T; Kalchman M; Hayden MR
    J Cell Biol; 1998 Jun; 141(5):1097-105. PubMed ID: 9606203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
    Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
    Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons.
    Jackson GR; Salecker I; Dong X; Yao X; Arnheim N; Faber PW; MacDonald ME; Zipursky SL
    Neuron; 1998 Sep; 21(3):633-42. PubMed ID: 9768849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsy brain.
    Dorsman JC; Smoor MA; Maat-Schieman ML; Bout M; Siesling S; van Duinen SG; Verschuuren JJ; den Dunnen JT; Roos RA; van Ommen GJ
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1061-7. PubMed ID: 10434306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.
    Schilling G; Becher MW; Sharp AH; Jinnah HA; Duan K; Kotzuk JA; Slunt HH; Ratovitski T; Cooper JK; Jenkins NA; Copeland NG; Price DL; Ross CA; Borchelt DR
    Hum Mol Genet; 1999 Mar; 8(3):397-407. PubMed ID: 9949199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice.
    Schilling G; Savonenko AV; Klevytska A; Morton JL; Tucker SM; Poirier M; Gale A; Chan N; Gonzales V; Slunt HH; Coonfield ML; Jenkins NA; Copeland NG; Ross CA; Borchelt DR
    Hum Mol Genet; 2004 Aug; 13(15):1599-610. PubMed ID: 15190011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregates.
    Chun W; Lesort M; Tucholski J; Ross CA; Johnson GV
    J Cell Biol; 2001 Apr; 153(1):25-34. PubMed ID: 11285271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.